Renal and Death Risks Lower with Metformin than Sulfonylureas - Renal and Urology News |
![]() |
Renal and Urology News PHILADELPHIA—Initiating treatment of type 2 diabetes with sulfonylurea drugs is associated with an increased risk of renal function decline, end-stage renal disease (ESRD), or death compared with starting treatment on metformin, according to study |